COVID 19
-
Health warnings after isolation scrapped AAP - 02-10-2022
The scrapping of COVID-19 isolation rules has come too soon after a string of major events that could lead to a spike in infections, doctors say. The head of
-
COVID-19 cases continue to drop nationally AAP - 23-09-2022
COVID-19 cases and deaths continue to fall across the country as experts question the utility of weekly virus data dumps. The federal health department released
-
Canada, Japan ease entry while WHO warns AAP - 23-09-2022
Canada is set to drop its vaccine requirement for people entering the country while Japan will also loosen border curbs as the World Health Organisation warns about a decline
-
Major step to booster for young children AAP - 22-09-2022
The medicines regulator has given provisional approval to a Pfizer COVID-19 vaccine booster for children aged five to 11. However the Therapeutic Goods Administration
-
Vic to trial COVID nasal spray treatment AAP - 21-09-2022
Clinical trials of a locally made nasal spray treatment for COVID-19 are set to begin in Victoria. The heparin spray, made at Monash University's Medicines
-
SA and NSW drop masks on public transport AAP - 20-09-2022
Commuters in NSW and South Australia will no longer legally have to wear masks on public transport, as Victoria ramps up compliance on its networks. The NSW
-
Public transport mask dodgers cop fines AAP - 19-09-2022
More than 100 fines have been issued on Victorian public transport and in excess of 181,000 warnings given as part of a COVID-19 mask compliance crackdown so far this September.
-
Pandemic end 'in sight' as stats released AAP - 17-09-2022
Public health experts are increasingly optimistic the end of the COVID-19 pandemic is in sight. The World Health Organisation has advised the pandemic could
-
WHO scraps support for two COVID therapies AAP - 17-09-2022
Two COVID-19 antibody therapies are no longer recommended by the World Health Organisation on the basis that Omicron and the variant's latest offshoots have almost certainly
-
A week to wait until next COVID stats AAP - 11-09-2022
At the height of COVID-19 the daily case numbers became popular viewing and reading, but in a sign the pandemic is easing, Australians will have to wait a week for the next
-
First COVID-19 jab more effective in males AAP - 06-09-2022
COVID-19 vaccines are more effective in males while females are more likely to experience negative side effects from their first jab, a new report shows. Australian
-
Young SA children to get COVID-19 vaccine AAP - 05-09-2022
About 5000 South Australian children aged under five who have pre-existing health issues are now eligible to receive a COVID-19 vaccine. The doses are being
-
UK approves updated Pfizer COVID vaccine AAP - 04-09-2022
An updated COVID-19 booster vaccine has been approved for use in the UK. The second "bivalent" vaccine, made by Pfizer/BioNTech, targets two coronavirus
-
Vic lifts work from home recommendation AAP - 02-09-2022
Victorians are being encouraged to return to the office, with the government lifting its work from home recommendation. With COVID-19 cases falling after last
-
Booster targeting Omicron strain approved AAP - 31-08-2022
Australia's medical regulators have given a green light for a COVID vaccine that will target the Omicron variant. The Therapeutic Goods Administration granted
-
Businesses back lowering COVID isolation AAP - 29-08-2022
The peak body for small businesses has backed a proposal to lower the isolation requirements for people who have tested positive for COVID. Wednesday's
-
Vaccine boss unsure about annual boosters AAP - 28-08-2022
The boss of pharmaceutical giant AstraZeneca is unsure whether annual COVID-19 boosters for otherwise healthy people are a good use of resources or money. A
-
Moderna sues Pfizer,BioNTech over vaccine AAP - 27-08-2022
Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they
-
Pandemic anxiety could drain $7b from NSW AAP - 26-08-2022
Rising rates of anxiety and depression caused by COVID-19 lockdowns could sap up to $7.4 billion from the NSW economy by 2025, a report suggests. The costing
-
COVID pill 'no benefit to younger adults' AAP - 26-08-2022
Pfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalisation and death for high-risk older users,
Article Search
To search for an article, enter a keyword term and click SEARCH
Practice Hubs
For practice specific information, select a field from the list below: